Episode Details

Back to Episodes

New Pill Doubles Survival for Pancreatic Cancer

Published 5 months, 2 weeks ago
Description
A new daily pill, daraxonrasib, has been shown to double survival time for patients with advanced pancreatic cancer, marking a significant breakthrough in treatment.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us